Aphton Corp. About
Aphton Corp. Aphton is a biopharmaceutical company developing
products using its innovative targeted immunotherapy technology for neutralizing
hormones that participate in gastrointestinal system and reproductive system cancer
and non-cancer diseases. Aphton has strategic alliances with Aventis Pasteur
for treating gastrointestinal system and other cancers with INSEGIA™ in North
America and Europe; GlaxoSmithKline for reproductive system cancer and non-cancer
diseases worldwide; and others. Insegia for Gastro-intestinal Cancer Insegia (G17DT
Immunogen) in combination with gemcitabine (GemzarŇ; Eli Lilly) for the treatment
of pancreatic cancer Recent News: Phase
3 Trial of Insegia in Pancreatic Cancer Does Not Meet Primary Endpoint
More Info on Aphton Corp